Improved survival with MEK inhibition in BRAF-mutated melanoma
KT Flaherty, C Robert, P Hersey… - … England Journal of …, 2012 - Mass Medical Soc
Background Activating mutations in serine–threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
Improved survival with MEK inhibition in BRAF-mutated melanoma.
K Flaherty, C Robert, P Hersey, P Nathan… - New England journal …, 2012 - ora.ox.ac.uk
BACKGROUND: Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
[引用][C] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
KT FLAHERTY, C ROBERT… - The New England …, 2012 - pascal-francis.inist.fr
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Improved survival with MEK inhibition in BRAF-mutated melanoma.
KT Flaherty, C Robert, P Hersey, P Nathan… - 1533 …, 2012 - escholar.manchester.ac.uk
BACKGROUND: Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
Improved survival with MEK inhibition in BRAF-mutated melanoma.
KT Flaherty, C Robert, P Hersey, P Nathan… - The New England …, 2012 - europepmc.org
Background Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
Improved survival with MEK inhibition in BRAF-mutated melanoma
K Flaherty, B Neyns - N Engl J Med, 2012 - researchportal.vub.be
BACKGROUND: Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
[引用][C] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
KT Flaherty, C Robert, P Hersey, P Nathan… - New England Journal …, 2012 - cir.nii.ac.jp
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
KT Flaherty, C Robert, P Hersey, P Nathan… - New England Journal …, 2012 - zora.uzh.ch
Background Activating mutations in serine–threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
[引用][C] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
KT Flaherty, C Robert, P Hersey… - New England …, 2012 - tobias-lib.ub.uni-tuebingen.de
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma Improved Survival with MEK
Inhibition in BRAF-Mutated Melanoma DSpace Repositorium (Manakin basiert) Einloggen …
Inhibition in BRAF-Mutated Melanoma DSpace Repositorium (Manakin basiert) Einloggen …
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
KT Flaherty, C Robert, P Hersey, P Nathan… - The New England …, 2012 - iro.uiowa.edu
BACKGROUND Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …
found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy …